Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
25 August 2023
Closing Date:
21 September 2023
Location(s):
PL416 Kaliski (PL Poland/POLSKA)
Description:
Successive supplies of pharmaceutical products — oncological drugs

Successive deliveries of pharmaceutical products – oncological drugs. The subject of the contract consists of 24 indivisible tasks, the detailed description of which, due to the limited number of characters, can be found in the Terms of Contract Specification

Fluorouracil and levofolic acid

Fluorouracil and levofolic acid

Cetuximab

Cetuximab

Abirateron

Abirateron

Axitinib

Axitinib

Doxorubicin liposomal

Doxorubicin liposomal

Rituximab

Rituximab

Avelumab

Avelumab

pazopanib

pazopanib

Kabazytaxel

Kabazytaxel

Sacituzumab govitecan

Sacituzumab govitecan

Enzalutamide

Enzalutamide

Irinotecan

Irinotecan

Methotexat

Methotexat

Vinblastine

Vinblastine

Calcium folinate

Calcium folinate

Paclitaxel

Paclitaxel

Ipilimumab

Ipilimumab

Cytotoxic drugs

Cytotoxic drugs

Fluvestrant

Fluvestrant

Vinorelbina doustna

Vinorelbina doustna

Vinorelbina dożylna

Vinorelbina dożylna

Oral drugs used in chemotherapy

Oral drugs used in chemotherapy

Drugs to support the treatment of cancer patients

Drugs to support the treatment of cancer patients

Darbapoetyna-alfa

Darbapoetyna-alfa

Download full details as .pdf
The Buyer:
Wojewódzki Szpital Zespolony im. L. Perzyny w Kaliszu
CPV Code(s):
33600000 - Pharmaceutical products